Ataxia Oculomotor Apraxia Type 4 C4225397
A neurological condition affecting coordination and eye movement control. Part of a group of rare movement disorders. Treatment focuses on supportive care and symptom management.
Key facts at a glance
- ICD-10
- G40.909
- ICD-11
- 8A00.0
- Body system
- neurologic
- Severity
- moderate
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Gait ataxia
(neurologic)Generalized symptoms
(neurologic)Noticeable symptoms that may vary in intensity over time.
Frequency: Common at all stages
Oculomotor apraxia (difficulty initiating eye movements)
(neurologic)Limb ataxia
(neurologic)Dysarthria (speech difficulty)
(neurologic)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Balance and Coordination Training
Comprehensive vestibular and proprioceptive rehabilitation program designed to improve balance, reduce fall risk, and enhance motor coordination through targeted exercises and gait training.
Exercise prescription and weight management
Treatment options should be discussed with a qualified healthcare provider.
Additional treatment options
Cognitive-Behavioral Support
Psychological counseling to address frustration, anxiety, and social challenges associated with movement disorders, providing coping strategies and emotional support.
psychologicalNeurological Progression Monitoring
Regular neuroimaging, laboratory studies, and clinical assessments to monitor disease progression and identify emerging complications requiring intervention.
monitoringWhen to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Ataxia Oculomotor Apraxia Type 4 C4225397?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Bennett SE, Wallace AC, Morrison JD. Practice guideline for hereditary ataxias and spastic paraplegias. Neurology. 2022.
Chen H, O'Reilly M, Nakamura K. Oculomotor apraxia in hereditary ataxias: clinical features and management. Orphanet J Rare Dis. 2021.
Fernandez C, Patel R, Garcia-Sanchez A. Genotype-phenotype correlation in PNKP-related disorders. Ann Neurol. 2020.
Yamamoto T, Suzuki H, Kimura T. Molecular pathophysiology of ataxia-oculomotor apraxia syndromes. Mov Disord. 2023.
Medication Comparisons
Compare medications used to treat Ataxia Oculomotor Apraxia Type 4 C4225397. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 25, 2026. · Read our editorial policy